Clinical Trial Update: Using Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Phase 4 trial investigating calcium dobesilate for mild to moderate non-proliferative diabetic retinopathy in Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Calcium dobesilate (calcium dobesilate)

Snippet

Sponsor: Zhongda Hospital | Conditions: Diabetic Retinopathy | Phase 4 | Status: UNKNOWN